查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1314477

局部止血剂市场：按产品和用途- 2023-2030 年全球预测

Topical Hemostat Market by Product, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年全球局部止血剂市场将大幅成长，达到41.0122亿美元，复合年增长率为7.57%，预计到2030年将达到68.4754亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球局部止血剂市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1.全球局部止血剂市场规模及预测为何？

2.在预测期内，COVID-19对全球局部止血剂市场的阻碍因素与影响为何？

3. 在预测期内，全球局部止血剂市场需要投资哪些产品/细分市场/用途/领域？

4.全球局部止血剂市场的竞争策略为何？

5.全球局部止血剂市场的技术趋势和法律规范是什么？

6.全球局部止血剂市场主要供应商的市占率是多少？

7. 哪些型态和策略性措施被认为适合进入局部止血剂的全球市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 全球血管外科的潜在需求
      • 由于具有成本效益，用途增加
      • 医疗法规机构的有利产品核可
    • 抑制因素
      • 这些产品缺乏报销政策
    • 机会
      • 微创手术新需求
      • 正在进行研发以推出新的局部止血剂
    • 任务
      • 局部止血剂的操作局限性
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户客製化

第6章局部止血剂市场：副产品

  • 介绍
  • 胶原蛋白基底
  • 组合
  • 明胶基质
  • 氧化再生纤维素基
  • 凝血酶碱基

第7章局部止血剂市场：依用途

  • 介绍
  • 医院
  • 疗养院
  • 手术中心

第8章美洲局部止血剂市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第9章亚太本地局部剂市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第10章欧洲、中东和非洲局部止血剂市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第11章竞争形势

  • FPNV定位矩阵
  • 市占率分析：主要企业
  • 竞争情境分析：主要企业

第12章上市公司名单

第13章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-031AB52F47EC

The Global Topical Hemostat Market is forecasted to grow significantly, with a projected USD 4,101.22 million in 2023 at a CAGR of 7.57% and expected to reach a staggering USD 6,847.54 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Topical Hemostat Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Topical Hemostat Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Collagen-Based Topical Hemostats, Combination Topical Hemostats, Gelatin-Based Topical Hemostats, Oxidized Regenerated Cellulose-based Topical Hemostats, and Thrombin-Based Topical Hemostats. The Thrombin-Based Topical Hemostats is projected to witness significant market share during forecast period.

Based on Application, market is studied across Hospitals, Nursing Homes, and Surgical Centers. The Nursing Homes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Topical Hemostat Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Topical Hemostat Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Topical Hemostat Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Topical Hemostat Market?

4. What is the competitive strategic window for opportunities in the Global Topical Hemostat Market?

5. What are the technology trends and regulatory frameworks in the Global Topical Hemostat Market?

6. What is the market share of the leading vendors in the Global Topical Hemostat Market?

7. What modes and strategic moves are considered suitable for entering the Global Topical Hemostat Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Topical Hemostat Market, by Product, 2022 vs 2030
  • 4.3. Topical Hemostat Market, by Application, 2022 vs 2030
  • 4.4. Topical Hemostat Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Potential demand in vascular surgeries across the world
      • 5.1.1.2. Increasing application attributed to its cost-effective nature
      • 5.1.1.3. Favorable product approval by medical regulators
    • 5.1.2. Restraints
      • 5.1.2.1. Dearth of reimbursement policies for these products
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging demand for minimally invasive surgical procedures
      • 5.1.3.2. Ongoing R&D for the introduction of novel topical hemostat
    • 5.1.4. Challenges
      • 5.1.4.1. Operational limitations of topical hemostat
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Topical Hemostat Market, by Product

  • 6.1. Introduction
  • 6.2. Collagen-Based Topical Hemostats
  • 6.3. Combination Topical Hemostats
  • 6.4. Gelatin-Based Topical Hemostats
  • 6.5. Oxidized Regenerated Cellulose-based Topical Hemostats
  • 6.6. Thrombin-Based Topical Hemostats

7. Topical Hemostat Market, by Application

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Nursing Homes
  • 7.4. Surgical Centers

8. Americas Topical Hemostat Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Topical Hemostat Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Topical Hemostat Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. TOPICAL HEMOSTAT MARKET RESEARCH PROCESS
  • FIGURE 2. TOPICAL HEMOSTAT MARKET SIZE, 2022 VS 2030
  • FIGURE 3. TOPICAL HEMOSTAT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. TOPICAL HEMOSTAT MARKET DYNAMICS
  • FIGURE 8. TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. TOPICAL HEMOSTAT MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. TOPICAL HEMOSTAT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. TOPICAL HEMOSTAT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. TOPICAL HEMOSTAT MARKET SIZE, BY COLLAGEN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. TOPICAL HEMOSTAT MARKET SIZE, BY GELATIN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. TOPICAL HEMOSTAT MARKET SIZE, BY THROMBIN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. TOPICAL HEMOSTAT MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. TOPICAL HEMOSTAT MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 101. TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 102. TOPICAL HEMOSTAT MARKET LICENSE & PRICING